Get more information on Ophthalmology PACS Market - Request Sample Report
The Ophthalmology PACS Market Size was esteemed at USD 152.50 million of every 2023, and is expected to arrive at USD 289.94 million by 2032, and develop at a CAGR of 7.4% over the gauge period 2024-2032.
PACS, also known as picture archiving and communication system, is a medical term used in the discipline of ophthalmology. It is largely used in healthcare organisations to digitally communicate and preserve securely electronic images and reports that are therapeutically important. The management of picture data takes place via the ophthalmology PACS, which reduces the need for manual information filing, archiving, and retrieval. A single report containing data from many modalities is made possible by the PACS system, which guarantees connection between various modalities. The ability to access all of the patient's data from a single system gives the end user another benefit. The system PACS is compact.
DRIVERS
Age-Related Population is Growing Rapidly
Eye diseases are becoming more common
There Are Not Many Ophthalmologists
Initiatives by the Government to Promote the Adoption of EHR/EMR
Increased use of teleophthalmology
RESTRAINS
Costly Implementation and Upkeep
OPPORTUNITIES
Emerging Markets Not Yet Used
Familiarity with EHR / EMR
Opportunities with High Growth Represented by Cloud-Based Platforms
CHALLENGES
Inadequate Compliance with Informatics Standards
Lockdowns, travel bans, and business closures brought on by the COVID-19 have had an impact on the economies and industries of many different nations. A number of facilities and plants have been shut down, which has had a severe influence on global supply chains, product production, delivery schedules, and international sales. Few businesses have already warned of potential delivery delays and a decline in future sales of their goods. The analysis examines the COVID-19 pandemic's effects both now and in the future on the market as a whole based on the state of the market, providing more accurate and authentic estimates. Additionally, the worldwide travel restrictions put in place by nations in Europe, Asia, and North America are limiting the chances for commercial relationships and collaborations.
By Type
Separated into integrated and standalone PACS, the ophthalmology PACS market is divided. In terms of market share for ophthalmology PACS, the integrated PACS sector is anticipated to lead. Integrated PACS have benefits including simple interoperability, mobility, data security, and cost-effectiveness. They are more likely to be adopted as a result of these benefits, which is fueling this market's expansion.
By Delivery Model
On-premise and web/cloud-based platforms are the two market segments for ophthalmology PACS. In terms of market share for ophthalmology PACS, on-premise versions are anticipated to dominate. On-premise models offer greater customization options than web/cloud-based ones, which may be the cause of this.
By End User
Hospitals, specialised clinics, outpatient surgical centers, and other end users comprise the segments of the ophthalmology PACS market. In terms of market share for ophthalmology PACS, specialty clinics & ambulatory surgery centers are anticipated to lead. This end-user segment's ophthalmology PACS market is anticipated to increase as a result of the expanding patient base for the diagnosis and treatment of cataracts at specialised clinics and ASCs due to affordable therapies.
By Type
Integrated PACS
Standalone PACS
By Delivery Model
On-premise
Web/cloud-based
By End User
Hospitals
Specialty Clinics & Ambulatory Surgery Centers
Other End Users
North America, then Europe, are the market's two biggest players. Age-related eye illnesses are becoming more prevalent, and this is one reason why the North American market is so dominant. Other factors influencing the use of ophthalmology PACS in this region include government initiatives toward digitization, rising EHR/EMR adoption, and growing use of data storage and sharing solutions.
Although there are many prospects for expansion in the ophthalmology sector, the substantial costs associated with these solutions' deployment and upkeep could restrict that growth.
Need any customization research on Ophthalmology PACS Market - Enquiry Now
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Some of the major key players are Agfa-Gevaert Group, Carl Zeiss Meditec AG, EyePACS, Heidelberg Engineering, IBM Corporation (Merge Healthcare), Canon USA Inc., VersaSuite, Medical Standard, ScImage, Topcon Corporation, Sonomed Escalon, Visbion and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 152.50 Million |
| Market Size by 2032 | US$ 289.94 Million |
| CAGR | CAGR of 7.4% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Integrated PACS, Standalone PACS) • By Delivery Model (On-premise, Web/cloud-based) • By End User (Hospitals, Specialty Clinics & Ambulatory Surgery Centers, Other End Users) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Agfa-Gevaert Group, Carl Zeiss Meditec AG, EyePACS, Heidelberg Engineering, IBM Corporation (Merge Healthcare), Canon USA Inc., VersaSuite, Medical Standard, ScImage, Topcon Corporation, Sonomed Escalon, Visbion. |
| DRIVERS | • Age-Related Population is Growing Rapidly • Eye diseases are becoming more common • There Are Not Many Ophthalmologists |
| RESTRAINTS | • Costly Implementation and Upkeep |
Ans: The Ophthalmology PACS Market Size was valued at USD 152.50 Mn in 2023.
Ans: The Ophthalmology PACS Market is growing at a CAGR of 7.4% over the forecast period 2024-2031.
Agfa-Gevaert Group, Carl Zeiss Meditec AG, EyePACS, Heidelberg Engineering, IBM Corporation (Merge Healthcare), Canon USA Inc. are the key players of Ophthalmology PACS market
North America, then Europe, are the market's two biggest players. Age-related eye illnesses are becoming more prevalent, and this is one reason why the North American market is so dominant.
Age-Related Population is Growing Rapidly, and Eye diseases are becoming more common are the key drivers of the Ophthalmology PACS market
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Ophthalmology PACS market Segmentation, By Type
8.1 Integrated PACS
8.2 Standalone PACS
9. Ophthalmology PACS Market Segmentation, By Delivery Model
9.1 On-premise
9.2 Web/cloud-based
10. Ophthalmology PACS Market Segmentation, By End User
10.1Hospitals
10.2 Specialty Clinics & Ambulatory Surgery Centers
10.3 Other End Users
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12. Company Profiles
12.1 Agfa-Gevaert Group
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 Carl Zeiss Meditec AG
12.3 EyePACS
12.4 Heidelberg Engineering
12.5 IBM Corporation (Merge Healthcare)
12.6 Canon USA Inc.
12.7 VersaSuite
12.8 Medical Standard
12.9 ScImage
12.10 Topcon Corporation
13. Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Bone Morphogenetic Protein Market size was estimated at USD 0.53 billion in 2023 and is expected to reach USD 0.72 billion by 2032 with a growing CAGR of 3.50% during the forecast period of 2024-2032.
The Covered Stent Market size was valued at USD 1.90 billion in 2023 and is expected to reach USD 2.69 billion by 2032 and grow at a CAGR of 3.96% over the forecast period 2024-2032.
Flash Chromatography Market was valued at USD 0.33 million in 2023, is projected to reach USD 0.50 million by 2032, growing at a CAGR of 4.6% from 2024 to 2032.
The Non-Invasive Fat Reduction Market Size was valued at USD 1.39 billion in 2023 and is expected to reach USD 4.67 billion by 2031, and grow at a CAGR of 16.3% over the forecast period 2024-2031.
The Biotechnology Reagents & Kits Market size was valued at USD 563.19 billion in 2023 and is expected to reach USD 1441.03 billion by 2032 at a CAGR of 11.04% during the forecast period of 2024-2032.
The STD diagnostics Market was valued at USD 10.05 Bn in 2023 and is expected to grow to USD 18.78 Bn by 2032, growing at a CAGR of 7.2% from 2024 to 2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
